Correlation Between IShares Healthcare and IShares Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Healthcare and IShares Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Healthcare and IShares Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Healthcare Providers and iShares Pharmaceuticals ETF, you can compare the effects of market volatilities on IShares Healthcare and IShares Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Healthcare with a short position of IShares Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Healthcare and IShares Pharmaceuticals.

Diversification Opportunities for IShares Healthcare and IShares Pharmaceuticals

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between IShares and IShares is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding iShares Healthcare Providers and iShares Pharmaceuticals ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Pharmaceuticals and IShares Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Healthcare Providers are associated (or correlated) with IShares Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Pharmaceuticals has no effect on the direction of IShares Healthcare i.e., IShares Healthcare and IShares Pharmaceuticals go up and down completely randomly.

Pair Corralation between IShares Healthcare and IShares Pharmaceuticals

Considering the 90-day investment horizon iShares Healthcare Providers is expected to under-perform the IShares Pharmaceuticals. In addition to that, IShares Healthcare is 1.48 times more volatile than iShares Pharmaceuticals ETF. It trades about -0.09 of its total potential returns per unit of risk. iShares Pharmaceuticals ETF is currently generating about -0.1 per unit of volatility. If you would invest  7,250  in iShares Pharmaceuticals ETF on August 30, 2024 and sell it today you would lose (326.00) from holding iShares Pharmaceuticals ETF or give up 4.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

iShares Healthcare Providers  vs.  iShares Pharmaceuticals ETF

 Performance 
       Timeline  
iShares Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Healthcare Providers has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Etf's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the Exchange Traded Fund stockholders.
iShares Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Pharmaceuticals ETF has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, IShares Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

IShares Healthcare and IShares Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Healthcare and IShares Pharmaceuticals

The main advantage of trading using opposite IShares Healthcare and IShares Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Healthcare position performs unexpectedly, IShares Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Pharmaceuticals will offset losses from the drop in IShares Pharmaceuticals' long position.
The idea behind iShares Healthcare Providers and iShares Pharmaceuticals ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital